StockData
Utah Medical Products Inc logo

Utah Medical Products Inc (UTMD) stock

UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/304% below fair value
$72.36+0.39 (+0.54%)

Close on Nov 16, 2026Market cap $230.38MP/E 22.1Yield –

Earnings

Utah Medical Products's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Jan 28, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$8.62M
-12.1% on a year earlier
Adjusted EPS, Q3 FY2026
$0.88
$0.82 a year earlier
Latest guidance
Issued
Oct 22, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Utah Medical Products's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Jan 28, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Oct 22, 2026during market hours$8.62M-12.1%$0.88–Release
Q2 FY2026ended Jun 30, 2026Jul 23, 2026during market hours$8.53M-14.3%$0.84–Release
Q1 FY2026ended Mar 31, 2026Apr 23, 2026during market hours$8.72M–$0.82–Release
Q4 FY2025ended Dec 31, 2025Jan 29, 2026during market hours$9.04M-1.2%$0.80–Release
Q3 FY2025ended Sep 30, 2025Oct 23, 2025during market hours$9.81M–$0.82–Release
Q2 FY2025ended Jun 30, 2025Jul 24, 2025during market hours$9.95M–$0.94–Release
Q1 FY2025ended Mar 31, 2025Apr 29, 2025during market hours––$0.92–Release
Q4 FY2024ended Dec 31, 2024Jan 28, 2025during market hours$9.16M-25.8%$0.86–Release
Q4 FY2023ended Dec 31, 2023Jan 30, 2024during market hours$12.33M-9.1%$1.18–Release
Q3 FY2023ended Sep 30, 2023Oct 26, 2023during market hours$12.51M–$1.08–Release
Q2 FY2023ended Jun 30, 2023Jul 25, 2023during market hours$12.87M-4.2%$1.15–Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Utah Medical Products's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
consolidated sales declineFY2026+7%–NewOct 22, 2026
sales declineFY2026-13% – -10%–NewJul 23, 2026
litigation expensesFY2026$1.60M–NewJul 23, 2026

Guidance history

Every forecast Utah Medical Products put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Oct 22, 2026consolidated sales declineFY2026+7%New
Jul 23, 2026litigation expensesFY2026$1.60MNew
Jul 23, 2026sales declineFY2026-13% – -10%New
Oct 23, 2025adjusted consolidated EBITDAFY2025$17.00M – $18.00MNew
Oct 23, 2025total annual consolidated salesFY2025-7%New
Jul 24, 2025EBITDA targetFY2025$17.00M – $18.00MLowered
Apr 29, 2025adjusted consolidated EBITDAFY2025$18.00MNew
Oct 26, 2023consolidated sales declineFY2023$2.00MNew
Oct 25, 2022adjusted consolidated EBITDAFY2022$28.00MLowered
Feb 1, 2022Adjusted consolidated EBITDAFY2022$30.00MRaised
Oct 26, 2021adjusted consolidated EBITDAFY2021$26.00MNew
Oct 26, 2021adjusted consolidated EBITDAFY2022$28.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Utah Medical Products filed with the SEC as exhibits to Form 8-K or 6-K

  1. News
  2. Results
  3. Update
  4. Results
  5. Results
  6. Results
  7. News
  8. Results
  9. Results
  10. Results
  11. Results
  12. News
  13. Results
  14. Results
  15. News

See a number that looks wrong?